NCT00117923View on ClinicalTrials.gov

Study With a Topical Gel to Treat Common Warts in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 31, 2004

Conditions
Warts
Interventions
DRUG

Resiquimod

Trial Locations (1)

97223

Oregon Medical Research Center, Portland

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY